Apply here 

Instituto De Oncología Intervencionista


Our Work

The Super-selective Intra-Arterial Chemotherapy (SSIAC) program was formed as a result of our aim to tend for our patients quality of life and treating their cases in an individualized basis by providing them with the best possible service and care.

We offer SSIAC as an alternative treatment for various types of malignancies, including pancreatic, lung, prostate, breast, and brain cancer.

Our services include standard and compassionate treatments that can improve a patient's survival, quality of life, reducing cancer symptoms, while minimizing drug side effects.

IDOI is considered a leader in brain tumor treatment, and is renowned for controlling the disease in over 60 patients with Diffuse Intrinsic Pontine Glioma (DIPG), with increased overall survival and quality of life.

IDOI’s drugs, delivery methods, and procedures have been granted approval in different countries around the world as an option for, among others, retinoblastoma, bone and liver cancers (see publications).

Our Origin

<p>The Instituto de Oncología Intervencionista is a multidisciplinary team officially founded in 2017 by doctors Alberto Jerónimo Siller Aguirre and José Alberto García de la Fuente after multiple instances of successful collaboration helping patients and giving hope back. Joining two successful professional careers and two complementary experiences, one focused on Oncology and the other on Interventional Neuroradiology, has allowed to find new ways of using multiple techniques, procedures, and medications to treat different types of cancer.</p>


<p>&nbsp;To attend isolated and complex cases of different types of cancer that require extraordinary measures through highly-effective techniques that do not deteriorate the clinical and immunological condition.</p>


<div>To be the global leaders in cancer treatments by improving the life quality of patients with negative diagnosis, employing the latest technological and scientific capabilities.</div>